Cargando…

MICA and NKG2D variants as risk factors in spondyloarthritis: a case–control study

The major histocompatibility complex class I polypeptide-related sequence A (MICA) glycoprotein mediates the activation of the natural killer group 2D receptor (NKG2D) expressed on NK and CD8+ T cells. A methionine or valine at position 129 in exon 3 results in strong (MICA129 met) or weak (MICA129...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fechtenbaum, Marie, Desoutter, Judith, Delvallez, Gauthier, Brochot, Etienne, Guillaume, Nicolas, Goëb, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768283/ https://www.ncbi.nlm.nih.gov/pubmed/30177859 http://dx.doi.org/10.1038/s41435-018-0044-x

Ejemplares similares

MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?
por: Risti, Matilde, et al.
Publicado: (2017)

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
por: Secchiari, Florencia, et al.
Publicado: (2022)

The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
por: Isernhagen, Antje, et al.
Publicado: (2015)

Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks
por: Isernhagen, Antje, et al.
Publicado: (2016)

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
por: Weiss-Steider, Benny, et al.
Publicado: (2011)

Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity
por: Luo, Qizhi, et al.
Publicado: (2020)

Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
por: Møller, Sofie H., et al.
Publicado: (2020)

The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies
por: Valés-Gómez, Mar
Publicado: (2015)

Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer
por: Chen, Jiong, et al.
Publicado: (2015)

The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation
por: Isernhagen, Antje, et al.
Publicado: (2015)

MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis
por: Wielińska, Joanna, et al.
Publicado: (2021)

NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells
por: Xing, Samantha, et al.
Publicado: (2020)

MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA
por: Kim, Younghoon, et al.
Publicado: (2020)

The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

Cell Surface Organization of Stress-inducible Proteins ULBP and MICA That Stimulate Human NK Cells and T Cells via NKG2D
por: Eleme, Konstantina, et al.
Publicado: (2004)

Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma
por: López-Cobo, Sheila, et al.
Publicado: (2018)

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma
por: Mantovani, Stefania, et al.
Publicado: (2020)

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells
por: Morimoto, Yoshihiro, et al.
Publicado: (2023)

Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway
por: Zhang, Jing, et al.
Publicado: (2023)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk
por: Lo, Paulisally Hau Yi, et al.
Publicado: (2013)

VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer
por: Wei, Xie, et al.
Publicado: (2016)

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
por: Alkhayer, Reem, et al.
Publicado: (2023)

False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney Donor
por: Desoutter, Judith, et al.
Publicado: (2016)

SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice
por: Ke, Mengyun, et al.
Publicado: (2016)

Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study
por: Onyeaghala, Guillaume, et al.
Publicado: (2019)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
por: Courau, Tristan, et al.
Publicado: (2019)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018)

Dielectric breakdown of 2D muscovite mica
por: Maruvada, Anirudh, et al.
Publicado: (2022)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

Transforming ground mica into high-performance biomimetic polymeric mica film
por: Pan, Xiao-Feng, et al.
Publicado: (2018)

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma
por: Zingoni, Alessandra, et al.
Publicado: (2018)

MICA*019 Allele and Soluble MICA as Biomarkers for Ankylosing Spondylitis in Taiwanese
por: Wang, Chin-Man, et al.
Publicado: (2021)

Targeting MICA with therapeutic antibodies for the treatment of cancer
por: Bonnafous, Cécile, et al.
Publicado: (2013)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
por: Kaidun, Polina, et al.
Publicado: (2023)

Layer-dependent stability of 2D mica nanosheets
por: Kim, Jae-Hun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dn3uu4pfjfjdipnkf2k7c5jvoj